Skip to content
MS
unreviewed

Fatty acid synthase

0 reactions · 0 pathways

What it does, reaction by reaction

0 reactions

This enzyme appears only in the regulation table, with no catalysed step recorded.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Fatty Acid Synthesis (De Novo Lipogenesis)

Accelerated by

Carbohydrate abundance; SREBP-1c and ChREBP transcriptional activation

Inhibited by

Product long-chain acyl-CoA feedback at the pathway level

Hormonal control

Insulin induces FAS; glucagon and fasting reduce expression

Recent literature

Europe PMC · from cache · sorted by publication date

  1. 1
  2. 2
  3. 3
    Thraustochytrid PUFA synthase ER domains form a stable heterodimer.

    Lofeudo N, Moncalian G. · 2026-06-10

    unreviewed
  4. 4
  5. 5
  6. 6
    STARD10 promotes progression of HER2+ breast cancer and intracellular lipid metabolism via the cAMP/PKA/CREB1 signaling axis.

    Liu S, Gao J, Niu Y, Dong X, Zhang Z, Teng X, Li Z, Zhang S, Meng Y, Gao MQ. · 2026-06-15

    open access unreviewed
  7. 7
  8. 8
    Integrated transcriptome and metabolome reveal <i>Mycoplasma hyopneumoniae</i> -induced lipid accumulation, inflammation, oxidative stress, and energy imbalance in the liver of pigs.

    Xue X, Bu Y, Yu C, Li J, Yang J, Gao M, Wang P, Gan Y, Zhang W, Fan S, Zhou R, Yin Z, Zheng X. · 2026-06-03

    open access unreviewed
  9. 9
  10. 10
    The role of protein palmitoylation in disease pathogenesis and therapeutic innovation.

    Lin X, Xing J, Jia K, Liu S, Liu Y, Gu Y, Guo K, Yi J. · 2026-05-29

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.